A J Loonen, W Soudijn
Index: Pharm. Weekbl. Sci. 7(1) , 1-9, (1985)
Full Text: HTML
Halopemide is a new psychotropic agent, a structural analogue of the neuroleptics of the butyrophenone type but with different pharmacological and clinical properties. Preliminary clinical findings indicate that halopemide lacks the ability to induce parkinsonism and may be an effective drug in the treatment of psychosis characterized by autism, emotional withdrawal or apathy. Its pharmacological effects at a molecular level in comparison to structurally related neuroleptics and putative metabolites are reviewed.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
halopemide
CAS:59831-65-1 |
C21H22ClFN4O2 |
|
CAY10593 inhibits the human P2X7 receptor independently of p...
2013-12-01 [Purinergic Signal. 9(4) , 609-19, (2013)] |
|
Dynamic cation-exchange systems for the separation of drugs ...
[J. Chromatogr. A. 164(2) , 177-85, (1979)] |
|
Endocrine effects of domperidone: a peripheral dopamine bloc...
1981-09-01 [Clin. Endocrinol. (Oxf.) 15(3) , 275-82, (1981)] |
|
Effects of halopemide on potassium-induced release of radiol...
1980-09-01 [Arch. Int. Pharmacodyn. Ther. 247(1) , 43-58, (1980)] |
|
Bromocriptine and apomorphine stimulation of cortisol secret...
1986-01-01 [Psychopharmacology 89(1) , 108-12, (1986)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
